







ANAND B. PITHADIA*, DINESHKUMAR M. PRAJAPATI, LALIT LATA JHA, FALGUNI TANDEL, NIKITA PATEL 
Parul Institute of Pharmacy, Vadodara, Gujrat, India 
Email: abpithadia@hotmail.com  
 Received: 25 Apr 2015 Revised and Accepted: 01 Jun 2015 
ABSTRACT 
Objective: To develop and validate simple, rapid, specific, accurate and precise bioanalytical method for determination of the HCG (Human 
Chorionic Gonadotropin) by RP-HPLC method by using human urine. 
Methods: The chromatographic separation was performed using Phenom enex C18 (250 x 4.6 mm, 5μ, 300 °A) column. Mobile phase composed of 
sodium phosphate buffer (pH 7.0, 0.05M) and acetonitrile (87.5:12.5 % v/v) at a flow rate of 1 ml/min. Detection was carried out using UV detector 
at 215 nm. Bovine serum albumin (BSA) was used as an internal standard (ISTD) and extraction was carried out using protein precipitation method. 
The method was validated as per USFDA guidelines. 
Results: The method was linear over the concentration range of 0.37 to 48.4 µg/ml. and correlation coefficient (R2
Conclusion: A simple, rapid, specific, accurate and precise analytical method was developed and validated by using human urine. 
) was found to be 0.9983 and the 
Lower limit of quantitation (LLOQ) was 0.37 µg/ml. Recovery was found more than 94.0% for HCG. The % CV for interday and intraday precision 
was found to be less than ˂1%. 
Keywords: RP-HPLC, HCG, BSA, Bioanalytical, Validation. 
 
INTRODUCTION 
Human chorionic gonadotropin (HCG) is a peptide or gonadotropin 
hormone produced in pregnancy that is made by the embryo soon 
after conception and later by the syncytiotrophoblast (part of the 
placenta). Its IUPAC name is (2S)-2-amino-6-[[(2R)-1-
(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl] amino]-6-
oxohexanoic acid and it is a water soluble hormone. It consists of 237 
amino acids; with an A chain containing 92 amino acids and B chain 
containing 145 amino acid. Its role is to prevent the disintegration of 
the corpus luteum of the ovary and thereby maintain progesterone 
production that is critical for a pregnancy in humans. Therapeutically 
it is mainly used in male infertility due to hypogonadotrophic 
hypogonadism, delayed puberty due to hypogonadism in the male and 
an ovulatory infertility. Diagnostically it is detected during pregnancy 
qualitatively [1, 2]. HPLC, LC-MS and LC-MS/MS methods are widely 
used for bioanalytical purpose as well as to determine drug in 
pharmaceutical dosage form [3, 5]. Literature reviews suggest that 
their enzyme based immunoassay methods available for 
determination of HCG in bio samples. However, these methods have 
some limitations which are minimized by HPLC based methods. HPLC 
method has following advantages over immunoassay method:  
1. High specificity, at low concentration. 
2. Internal standards (BSA), correct matrix effects and hence 
improves accuracy.  
3. Wide range of the calibration curve available. 
4. Lower inter-laboratory variability and lower variability among 
different immunoassay kits [4]. 
Hence present research work describes the simple, rapid, accurate, 
sensitive and reproducible RP-HPLC based bioanalytical method for 
determination of HCG in urine.  
 
Fig. 1: Structure of HCG [1] 
 
Fig. 2: Structure of BSA [1] 
 
MATERIALS AND METHODS 
Instrument and analytical conditions 
The HPLC analysis was carried out using shimadzu (LC-20AD) 
binary gradient pump with UV detector and running as spin chrome 
software. The column used was Phenom enex C18 (250 x 4.6 mm, 
5μ, 300 °A) column at the flow rate as 1 ml/min. and detection was 
performed as 215 nm. The injection volume of the sample was 20 µl. 
and the mobile phase was made of sodium phosphate buffer (pH 7.0, 
0.05M) and acetonitrile (87.5:12.5 % v/v). The mobile phase was 
filtered through 0.45 µm membrane filter and sonicated before use. 
Reagents and chemicals 
Triple distilled water was used for the HPLC experiment. HPLC 
grade acetonitrile, HCG and other reagents were commercially 
purchased and were of AR grade.  
Preparation of mobile phase  
Accurately weighed 1.8 gm of disodium hydrogen phosphate and 1.5 
gm sodium dihydrogen phosphate were separately transferred into 
250 ml volumetric flasks and finally volume was adjusted with triple 
distilled water, and then degassed through sonicator. This solution 
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was prepared as 0.05M and pH adjusted 7.0 with ortho phosphoric 
acid solution. Sodium phosphate buffer and acetonitrile take in the 
ratio of (87.5:12.5) into the mobile phase bottle. Then filtered 
through 0.45µ nylon membrane filter and degassed. Mobile phase 
was used as diluents. 
Preparation of sample and dilution pattern for HCG using urine 
as a matrix 
Standard stock solution was prepared by dissolving 100 mg of HCG 
transferred into 100 ml volumetric flasks and adjusted with diluents. 
A series of its working solutions were prepared in order to make the 
concentration of 0.37, 0.74, 2.42, 7.2, 24.2, 36.3, 43.5 and 48.4 µg/ml 
in each 500 µl normal human urine and 1000 µl acetone. The 
internal standard was prepared having a concentration 24.2 µg/ml 
in diluents. All above solution were spiked with 24.2 µg/ml working 
internal standard solution and vortexes for 30 second before 
extraction. Extraction was done using acetone. 
Chromatographic conditions 
Chromatographic analysis was performed on a Phenomenex C18 
(250 x 4.6 mm, 5μ, 300 °A) column. The mobile phase consists of 
sodium phosphate buffer: acetonitrile (87.5:12.5% v/v). The mobile 
phase was filtered through the membrane filter and degassed before 
pumping into HPLC system.  
Mobile phase: Sodium phosphate buffer: water (87.5:12.5% v/v). 
Flow rate: 1 ml/min. 
Detection wavelength: 215 nm. 
Injected volume: 20 µl. 
Column temperature: Ambient. 
Method validation 
The developed chromatographic method was validated for system 
suitability, specificity, linearity and range, accuracy, precision, 
recovery, and stability as per USFDA guidelines [9-11]. 
RESULTS AND DISCUSSION 
Method development and optimization 
To optimize the HPLC methods, several mobile phase composition 
was tried. A satisfactory peak separation, resolution, theoretical 
plate and tailing factor for both drug and internal standard were 
found good with mobile phase sodium phosphate buffer (pH 7.0, 
0.05M): acetonitrile (87.5:12.5 % v/v) at a flow rate of 1 ml/min. 
Standard solution of HCG was scanned over the range of 200-400 
nm and the wavelength was selected according to reported 
wavelength 215 nm. Retention time was observed as 5.279 min. and 
2.343 min. for HCG and internal standard (BSA) respectively.  
System suitability 
System suitability was checked of a system to ensure system 
performance before or during the analysis of unknowns. Parameters 
such as theoretical plate count, tailing factors, resolution and 
reproducibility in retention time (RT) for six repetitions of 100% 
concentration of HCG and BSA was also explored to comply the 
system suitability test. The result of system suitability is shown in 
table: 1 and table: 2. 
 
Table 1: System suitability parameters of developed bioanalytical method 
S. No. Retention time  Tailing factor Resolution  Theoretical plate 
n=6 HCG ISTD HCG ISTD HCG ISTD HCG ISTD 
1. 5.278 2.341 1.152 1.225 13.350 0.00 3262 2146 
2. 5.279 2.340 1.151 1.223 13.410 0.00 3207 2132 
3. 5.280 2.345 1.150 1.224 13.370 0.00 3277 2179 
4. 5.281 2.342 1.151 1.226 13.267 0.00 3254 2150 
5. 5.279 2.343 1.150 1.225 13.432 0.00 3289 2194 
6 5.279 2.344 1.152 1.226 13.290 0.00 3227 2162 
  
Specificity 
Specificity was checked for interference of the matrix in the 
analysis of injecting the sample solution under optimized 
chromatographic condition. It contains one blank, one double 
blank and one standard peak. The peaks purity was found to be 
good and no interference was found for both drug and ISTD. 
Percentage coefficient of variation (%CV) of retention time was 
found 9.47% for HCG and 0.040% for ISTD which are within the 
acceptance range hence it could be said that the developed 
method was highly specific. The result of specificity is shown in 
the table: 3 and table: 4.  
 
 
Fig. 3: Chromatogram of blank (Urine Matrix) 
 
Fig. 4: Chromatogram of double blank (Urine Matrix+ISTD) 
 
 
Fig. 5: Chromatogram of standard (Urine Matrix+ISTD+Drug) 
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Table 2: Acceptance criteria of system suitability 
Parameter  Acceptance criteria HCG ISTD 
Retention time  <2 %CV 5.279±0.00942 2.343±0.00170 
Tailing factor <1.5 1.151±0.000816 1.224±0.00106 
Resolution >2 13.353±0.0593 0.00±0.00 
Theoretical plate >2000 3261±28.005 2160.5±20.814 
 
Table 3: Specificity of HCG 
S. No. 
n=6 
Urine sample Interference at retention time of drugs  Interference at retention time of ISTD 
Retention time (min) Peak area Retention time Peak area 







Table 4: Specificity of HCG (Extracted LLOQ sample) 
 Extracted LLOQ samples 
Sample No. n=6  HCG  Internal standard 
RT (min) Peak Area RT (min) Peak Area 
1 5.279 26589 2.342 38779 
2 5.278 26541 2.342 38845 
3 5.278 26540 2.341 38782 
4 5.279 26579 2.342 38989 
5 5.279 26603 2.344 38752 
6 5.278 26591 2.343 39193 
Mean 5.278 26573.83 2.342 38890 
SD 0.0005 24.5792 0.00094 18.2452 
%CV 9.47% 0.0924% 0.040% 0.046% 
  
Linearity and range 
Various concentrations from standard HCG, working solution of HCG 
and ISTD were prepared and calibration graph was plotted between 
the peak area and concentration (µg/ml). It was found to be linear 
over the concentration range of 0.37µg/ml to 48.4 µg/ml with 
R2value 0.9983. Eight concentrations of solutions were prepared 
according to the C max 
 
Fig. 6: Overlay chromatogram of standard solution 
 
Accuracy 
value of the drug. The result of linearity and 
range is shown in the table: 5.  
 
It is defined as the closeness of mean test results obtained by the 
method to the actual value (concentration) of the analyte. The 
accuracy of the method was established using recovery technique 
(ISTD was also added). Minimum five determinations per 
concentrations were done to determine LQC, MQC and HQC. 
Accuracy for HCG was found to be 97.20% to 101.29%, which lies 
within the acceptance range of±15% and±20% for LQC, MQC and 
HQC respectively. The result of % accuracy and % CV is shown in 
table: 6 and table: 7. 
Precision 
It is defined as the closeness of individual measures of an analyte 
when the procedure is applied repeatedly to multiple aliquots of 
single homogenous volume of biological matrix. The precision of the 
developed method was studied by interday precision and intraday 
precision method. Minimum five determinations per concentrations 
were done to determine LQC, MQC and HQC. Repeatability of the 
method was checked by injecting each concentration solution for 
five times on the same day as intraday precision and injecting each 




Fig. 6: Calibration curve for HCG
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Table 5: Linearity data of HCG 
S. No. Concentration of HCG Area of HCG Area of internal standard Area of HCG/Area of I. S. 
1 0.37 26589 39184 0.6785 
2 0.74 27944 38810 0.7200 
3 2.4 28872 39221 0.7361 
4 7.2 33877 39120 0.8659 
5 24.2 46780 39157 1.1946 
6 36.3 57205 38779 1.4751 
7 43.5 62480 39206 1.5936 
8 48.4 67859 38998 1.7400  
 
Table 6: Accuracy for HCG 
QC Samples Conc. 
(µg/ml) 
n=5 
Area ratio= Area of HCG 
Area of ISTD 
Mean %Accuracy 
Set1 Set 2 Set 3 Set 4 Set 5 
LQC 1.11 0.7102 0.7137 0.7140 0.7128 0.7181 0.7137 97.20% 
MQC 24.2 1.1946 1.2042 1.1950 1.1974 1.2039 1.1990 97.80% 
HQC 36.3 1.4599 1.4703 1.4702 1.4611 1.4785 1.468 101.29% 
 
Table 7: % CV obtained for accuracy of HCG 
 LQC MQC HQC 
Concentration 1.11 24.2 36.3 
Mean  0.7137 1.1990 1.468 
SD 0.002549 0.004218 0.006835 
% CV 0.3571% 0.3517% 0.4655% 
 
Table 8: Intraday precision for HCG 
QC Samples Conc. 
(µg/ml) 
n=5 
Area ratio= Area of HCG 
Area of ISTD 
Mean SD %CV 
Set1 Set 2 Set 3 Set 4 Set 5 
LQC 1.11 0.7201 0.7141 0.7184 0.7166 0.7193 0.7277 0.00214 0.2940% 
MQC 24.2 1.1966 1.2023 1.1943 1.1982 1.2031 1.1989 0.00335 0.2794% 
HQC 36.3 1.4740 1.4725 1.4728 1.4656 1.4605 1.4690 0.00307 0.2089% 
 
Table 9: Interday precision for HCG (Day 1) 
Day 1 
QC Samples Conc. 
(µg/ml) 
n=5 
Area ratio= Area of HCG 
Area of ISTD 
Mean SD %CV 
Set1 Set 2 Set 3 Set 4 Set 5 
LQC 1.11 0.7201 0.7141 0.7184 0.7166 0.7193 0.7277 0.00214 0.2940% 
MQC 24.2 1.1966 1.2023 1.1943 1.1982 1.2031 1.1989 0.00335 0.2794% 
HQC 36.3 1.4740 1.4725 1.4728 1.4656 1.4605 1.4690 0.00307 0.2089% 
 
Table 10: Interday precision for HCG (Day 2) 
Day 2 
QC Samples Conc. 
(µg/ml) 
n=5 
Area ratio= Area of HCG 
Area of ISTD 
Mean SD %CV 
Set1 Set 2 Set 3 Set 4 Set 5 
LQC 1.11 0.7196 0.7193 0.7180 0.7148 0.7190 0.7191 0.00175 0.2433% 
MQC 24.2 1.2000 1.1958 1.1979 1.1959 1.1992 1.1977 0.00169 0.1411% 
HQC 36.3 1.4617 1.4731 1.4744 1.4704 1.4696 1.4698 0.00442 0.3007% 
 
Table 11: Interday precision for HCG (Day 3) 
Day 3 
QC Samples Conc. 
(µg/ml) 
n=5 
Area ratio= Area of HCG 
Area of ISTD 
Mean SD %CV 
Set1 Set 2 Set 3 Set 4 Set 5 
LQC 1.11 0.7195 0.7190 0.7182 0.7140 0.7187 0.7178 0.00198 0.2758% 
MQC 24.2 1.1947 1.2038 1.2000 1.1968 1.1964 1.1983 0.00322 0.2687% 
HQC 36.3 1.4592 1.4591 1.4646 1.4716 1.4691 1.4647 0.00507 0.3461% 
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Intraday precision for HCG 
% CV of intraday precision for MQC and HQC were found to be 
0.1411 to 0.3461%, which lies within the acceptance range of±15%. 
% CV for LQC sample was found to be 0.2433% to 0.2940%, which 
lies within the acceptance range of±20%. % CV of intraday precision 
is shown in the table: 8. 
Interday precision for HCG 
% CV of intraday precision for MQC and HQC were found to be 
0.1411 to 0.3461%, which lies within the acceptance range of±15% 
and % CV for LQC sample was found to be 0.2433% to 0.2940%, 
which lies within the acceptance range of±20%. The % CV of 
intraday precision is shown in the table: 9, table: 10 and table: 11. 
Recovery 
It is defined as the detector response obtained from an amount of 
analyte added and extracted from the biological matrix. Recovery 
should not be 100%. Repeatability was checked by injecting each 
concentration of six determinations such as LQC, MQC and HQC 
respectively. % recovery of HCG for LQC, MQC and HQC was found to 
be 94.98%, 95.88% and 95.21% respectively which is in the 
acceptance limit less than 100%. The result of recovery is shown in 
the table: 12, table: 13 and table: 14. 
 




 Human Chorionic Gonadotropin (HCG) 
Area ratio of extracted Area ratio of post extracted % Recovery 
1 0.7191 0.7513 95.71% 
2 0.7140 0.7491 95.31% 
3 0.7169 0.7583 94.54% 
4 0.7132 0.7545 94.52% 
5 0.7142 0.7515 95.03% 
6 0.7137 0.7530 94.78% 
Mean 0.7151 0.7529 94.98% 
SD 0.00211 0.00290 0.4261 
%CV 0.2950% 0.3851% 0.4486% 
 




 Human Chorionic Gonadotropin (HCG) 
Area ratio of extracted Area ratio post extracted % Recovery 
1 1.1995 1.2578 95.36% 
2 1.1943 1.2578 94.95% 
3 1.2039 1.2319 97.72% 
4 1.1926 1.2520 95.25% 
5 1.1945 1.2477 95.73% 
6 1.2013 1.2475 96.29% 
Mean 1.1976 1.2491 95.88% 
SD 0.00413 0.00875 0.9227 
%CV 0.3448% 0.7005 0.9623% 
 




 Human Chorionic Gonadotropin (HCG) 
Area ratio of extracted Area ratio post extracted % Recovery 
1 1.4614 1.5244 95.86% 
2 1.4616 1.5249 95.84% 
3 1.4609 1.5250 95.79% 
4 1.4661 1.5324 95.37% 
5 1.4620 1.5265 95.77% 
6 1.4688 1.5255 96.28% 
Mean 1.4684 1.5264 95.21% 
SD 0.00294 0.00273 0.2343 
%CV 0.2002% 0.1788% 0.2460% 
 
Stability study 
Different stability studies for HCG including short term stability, freeze 
thaw stability, long term stability and stock solution stability were 
performed as per USFDA guideline and observed data are given in 
table: 15 to table: 19. % CV is observed within acceptance criteria. 
Short term stability study 
Stability was done in biological sample and aliquot of low and high 
should be kept for minimum 7 hours at room temperature.  
Long term stability study 
The stability study was done for the time between 0 to 10 days. 
Freeze-thaw solution stability 
The stability study was done for minimum three freeze thaw cycle. 
Spiked sample at LQC and HQC levels were stored in deep freezer for 
at least 24 hrs for FT cycle 1. Then thaw at room temperature. This 
process was again repeated for 2 to 3 freeze-thaw cycle and then 
compare with fresh sample. 
Stock solution stability 
The stability study was done for the time between 0 to 6 hr at room 
temperature and the time between 0 to 10 days at refrigerated 
condition (2-8 °C) for the drug and internal standard. 
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Table 15: Short term stability for HCG 
QC Samples LQC HQC 
S. No. 
n=5 
 Area ratio of HCG Area ratio of HCG 
Fresh After 7 hr Fresh After 7 hr 
1 0.7200 0.7194 1.4624 1.4628 
2 0.7197 0.7185 1.4640 1.4626 
3 0.7194 0.7181 1.4630 1.4633 
4 0.7194 0.7196 1.4615 1.4627 
5 0.7193 0.7187 1.4617 1.4640 
Mean 0.7195 0.7188 1.4625 1.4640 
SD 0.00025 0.00056 0.00091 0.00051 
%CV 0.0347% 0.0779% 0.0622% 0.0348% 
 
Table 16: Long term stability for HCG 
QC Samples LQC HQC 
S. No. 
n=5 
 Area ratio of HCG Area ratio of HCG 
Fresh After  10 days Fresh After  10 days 
1 0.7202 0.7199 1.4616 1.4616 
2 0.7202 0.7196 1.4615 1.4618 
3 0.7191 0.7203 1.4619 1.4620 
4 0.7191 0.7200 1.4608 1.4609 
5 0.7195 0.7185 1.4606 1.4607 
Mean 0.7196 0.7196 1.4612 1.4614 
SD 0.00049 0.00028 0.00049 0.00050 
%CV 0.0680% 0.0389% 0.0335% 0.0342% 
 
Table 17: Freeze Thaw stability for HCG 
QC Samples LQC HQC 
S. No. 
n=5 
 Area ratio of HCG Area ratio of HCG 
Fresh After 3 cycles Fresh After 3 cycles 
1 0.7193 0.7192 1.4632 1.4628 
2 0.7196 0.7189 1.4620 1.4619 
3 0.7208 0.7204 1.4612 1.4619 
4 0.7209  0.7200 1.4608 1.4617 
5 0.7206 0.7192 1.4615 1.4620 
Mean 0.7202 0.7195 1.4617 1.4620 
SD 0.00065 0.00064 0.00082 0.00038 
%CV 0.0902% 0.0889% 0.0560% 0.0259% 
 
Stock solution stability at room temperature 
Table 18: Stock solution stability for HCG at room Temperature after 6 hrs 
QC Samples LQC HQC 
S. No. 
n=5 
 Area ratio of HCG Area ratio of HCG 
Fresh After 6 hr at RT Fresh After 6 hr at RT 
1 0.7188 0.7181 1.4629 1.4628 
2 0.7202 0.7197 1.4625 1.4625 
3 0.7199 0.7201 1.4632 1.4628 
4 0.7198 0.7199 1.4637 1.4631 
5 0.7190 0.7202 1.4630 1.4629 
Mean 0.7195 0.7196 1.4630 1.4628 
SD 0.00054 0.000769 0.000392 0.000193 
%CV 0.0750% 0.1068% 0.0267% 0.0131% 
 
Stock solution stability at Refrigerated Condition (2-8˚C) for 10 days 
Table 19: Stock solution stability for HCG at Refrigerated Condition (2-8˚C) for 10 days 
QC Samples LQC HQC 
S. No.  n=5  Area ratio of HCG Area ratio of HCG 
Fresh After 10 days at 2-8 ˚C Fresh After 10 days at 2-8 ˚C 
1 0.7198 0.7195 1.4631 1.4621 
2 0.7197 0.7190 1.4630 1.4635 
3 0.7192 0.7184 1.4614 1.4621 
4 0.7192 0.7191 1.4634 1.4640 
5 0.7194 0.7197 1.4637 1.4637 
Mean 0.7194 0.7191 1.4692 1.4630 
SD 0.000249  0.000449 0.000798 0.000815 
%CV 0.0346% 0.0624% 0.0543% 0.0557% 
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CONCLUSION 
In present work, human chorionic gonadotropin (HCG) was estimated 
in human urine by RP-HPLC method. The developed method is highly 
accurate, precise and specific. It is validated as per USFDA guideline. 
The method was developed in the mobile phase sodium phosphate 
buffer (pH 7.0, 0.05M): acetonitrile (87.5:12.5 % v/v) with flow rate 1 
ml/min. at 215 nm. Bovine serum albumin (BSA) was used as an 
internal standard. Very high extraction efficiency (more than 94%) 
and LLOQ were found to be 0.37 µg/ml. Calibration curve was linear 
within the range of 0.37 to 48.4 µg/ml. R2
The authors are thankful to Parul Institute of Pharmacy, Vadodara for 
providing the necessary facilities to carry out the above research work. 
 value was found to be 
0.9983 and accuracy was found for LQC, MQC and HQC in between 
97.20% to 101.29%. Precision for HCG was found for LQC, MQC and 
HQC was 0.14 to 0.367 %CV respectively. Stability study like short 
term, freeze and thaw, long term, and stock solution stability were 
performed and drug was found to be stable, throughout the study. 
Thus, this method can be useful for determination of HCG in biological 
samples in clinical and biomedical research.  
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